Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could 2023 Be a Breakout Year for This Pharma Stock?

TheMotleyFool

0 0

Could 2023 Be a Breakout Year for This Pharma Stock?: https://g.foolcdn.com/editorial/images/684419/medical-professional-looking-at-hand-of-patient.jpg

A Food and Drug Administration (FDA) approval for a highly anticipated treatment is the kind of news that can make a company's stock skyrocket, even during a bear market -- like the one we're in now.

One company hoping for such success is Arcutis Biotherapeutics (NASDAQ: ARQT). It has been developing a treatment for Seborrheic dermatitis -- a skin disorder that causes scaly skin, or dandruff-like flakes, on the face and scalp. It affects 7% of the global population. There are treatments on the market, but none has been developed that can clear it up for good. So companies that develop a successful way to fight the disease have a promising opportunity.

Source Fool.com

Like: 0

ARQT

Share